{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:46:52Z","timestamp":1782301612360,"version":"3.54.5"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>A complex network of hormones and other effectors characterize the hypermetabolic response in critical illness; these mediators work together to induce numerous pathophysiologic alterations. Increased incidence of infection, multiorgan failure, long-term debilitation, delays in rehabilitation, and death result from an inability to meet the prohibitively elevated protein and energy requirements, which occur during illness and can persist for several years. Pharmacologic interventions have been successfully utilized to attenuate particular aspects of the hypermetabolic response; these modalities are a component of managing critically ill patients \u2013 including those patients with severe burns. Here, we review recent advances in pharmacologically attenuating the hypermetabolic and catabolic responses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Propranolol, a nonspecific \u03b2-adrenergic receptor antagonist, is one of the most widely used anticatabolic therapies. Oxandrolone, testosterone, and intensive insulin therapy represent anabolic pharmacological strategies. Promising therapies, such as metformin, glucagon-like peptide 1, peroxisome proliferator-activated receptor agonists, are currently being investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Profound metabolic derangements occur in critically ill patients; this hypermetabolic response is a major contributor to adverse outcomes. Despite the pharmacological therapies currently available to counteract this devastating cascade, future studies are warranted to explore new multimodality agents that will counteract these effects while maintaining glycemic control and preventing unfavorable complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000330","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T13:41:05Z","timestamp":1465566065000},"page":"325-331","source":"Crossref","is-referenced-by-count":30,"title":["Anabolic and anticatabolic agents in critical care"],"prefix":"10.1097","volume":"22","author":[{"given":"Mile","family":"Stanojcic","sequence":"first","affiliation":[{"name":"Sunnybrook Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste C.","family":"Finnerty","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Texas Medical Branch"},{"name":"Shriners Hospitals for Children \u2013 Galveston"},{"name":"Institute for Translational Sciences, The University of Texas Medical Branch, Galveston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Jeschke","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, Toronto, Ontario, Canada"},{"name":"Department of Surgery, Division of Plastic Surgery"},{"name":"Department of Immunology, University of Toronto"},{"name":"Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccc.2010.04.001","article-title":"The evolutionary role of nutrition and metabolic support in critical illness","volume":"26","author":"Mongardon","year":"2010","journal-title":"Crit Care Clin"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10253890701288935","article-title":"Evolution of concepts of stress","volume":"10","author":"Goldstein","year":"2007","journal-title":"Stress"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/SLA.0b013e3181856241","article-title":"Pathophysiologic response to severe burn injury","volume":"248","author":"Jeschke","year":"2008","journal-title":"Ann Surg"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cps.2009.05.001","article-title":"The hypermetabolic response to burn injury and interventions to modify this response","volume":"36","author":"Williams","year":"2009","journal-title":"Clin Plast Surg"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"e21245","DOI":"10.1371\/journal.pone.0021245","article-title":"Long-term persistance of the pathophysiologic response to severe burn injury","volume":"6","author":"Jeschke","year":"2011","journal-title":"PLoS One"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1210\/jc.2008-1947","article-title":"Abnormal insulin sensitivity persists up to three years in pediatric patients postburn","volume":"94","author":"Gauglitz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archsurg.139.6.641","article-title":"Extended hypermetabolic response of the liver in severely burned pediatric patients","volume":"139","author":"Jeschke","year":"2004","journal-title":"Arch Surg"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(04)16360-5","article-title":"Support of the metabolic response to burn injury","volume":"363","author":"Herndon","year":"2004","journal-title":"Lancet"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"R10-20230913","first-page":"657","article-title":"Insulin receptor down-regulation and impaired antilipolytic action of insulin in diabetic patients after pancreas\/kidney transplantation","volume":"78","author":"Boden","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/diabetes.51.2.301","article-title":"Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans","volume":"51","author":"Shah","year":"2002","journal-title":"Diabetes"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI5001","article-title":"Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity","volume":"103","author":"Dresner","year":"1999","journal-title":"J Clin Invest"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diacare.27.1.77","article-title":"Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study","volume":"27","author":"Pankow","year":"2004","journal-title":"Diabetes Care"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/msy.2000.108059","article-title":"Persistence of muscle catabolism after severe burn","volume":"128","author":"Hart","year":"2000","journal-title":"Surgery"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000658-200010000-00001","article-title":"Determinants of skeletal muscle catabolism after severe burn","volume":"232","author":"Hart","year":"2000","journal-title":"Ann Surg"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/endo.130.1.1727716","article-title":"Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output","volume":"130","author":"Lang","year":"1992","journal-title":"Endocrinology"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/00003246-200107000-00004","article-title":"Efficacy of a high-carbohydrate diet in catabolic illness","volume":"29","author":"Hart","year":"2001","journal-title":"Critical care medicine"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.burns.2004.08.006","article-title":"Effects of growth hormone on anthropometric measurements and cardiac function in children with thermal injury","volume":"31","author":"Mlcak","year":"2005","journal-title":"Burns"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00024382-200304000-00004","article-title":"Growth hormone down-regulation of interleukin-1beta and interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3","volume":"19","author":"Wu","year":"2003","journal-title":"Shock"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0305-4179(00)00164-9","article-title":"The effect of short-term growth hormone treatment on growth and energy expenditure in burned children","volume":"27","author":"Aili Low","year":"2001","journal-title":"Burns"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jamcollsurg.2009.01.022","article-title":"Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs","volume":"208","author":"Williams","year":"2009","journal-title":"J Am Coll Surg"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/SLA.0b013e3181b8f9ca","article-title":"Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children","volume":"250","author":"Branski","year":"2009","journal-title":"Ann Surg"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","article-title":"Increased mortality associated with growth hormone treatment in critically ill adults","volume":"341","author":"Takala","year":"1999","journal-title":"New Engl J Med"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1210\/en.2004-1037","article-title":"Insulin-like growth factor I: the yin and yang of muscle atrophy","volume":"145","author":"Heszele","year":"2004","journal-title":"Endocrinology"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/00003246-200005000-00053","article-title":"Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response","volume":"28","author":"Jeschke","year":"2000","journal-title":"Crit Care Med"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00003246-200201000-00013","article-title":"Modulation of types I and II acute phase reactants with insulin-like growth factor-1\/binding protein-3 complex in severely burned children","volume":"30","author":"Spies","year":"2002","journal-title":"Crit Care Med"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccc.2005.09.005","article-title":"Glucose metabolism and insulin therapy","volume":"22","author":"Langouche","year":"2006","journal-title":"Crit Care Clin"},{"issue":"(Suppl 1)","key":"R28-20230913","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0168-8227(11)70014-6","article-title":"Insulin effects in muscle and adipose tissue","volume":"93","author":"Dimitriadis","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.sla.0000161028.43338.cd","article-title":"Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences","volume":"241","author":"Jeschke","year":"2005","journal-title":"Ann Surg"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.sla.0000118569.10289.ad","article-title":"Insulin treatment improves the systemic inflammatory reaction to severe trauma","volume":"239","author":"Jeschke","year":"2004","journal-title":"Ann Surg"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1067\/msy.2002.126871","article-title":"The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn","volume":"132","author":"Thomas","year":"2002","journal-title":"Surgery"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N Engl J Med"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/jc.2007-0813","article-title":"Effect of intensive insulin therapy on insulin sensitivity in the critically ill","volume":"92","author":"Langouche","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.290.15.2041","article-title":"Glucose control and mortality in critically ill patients","volume":"290","author":"Finney","year":"2003","journal-title":"JAMA"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"R36-20230913","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/SLA.0b013e3181f2774c","article-title":"Glucose control in severely thermally injured pediatric patients: what glucose range should be the target?","volume":"252","author":"Jeschke","year":"2010","journal-title":"Ann Surg"},{"key":"R37-20230913","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1152\/japplphysiol.00849.2002","article-title":"Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns","volume":"94","author":"Suman","year":"2003","journal-title":"J Appl Physiol (1985)"},{"key":"R38-20230913","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1097\/00003246-200110000-00015","article-title":"Testosterone administration in severe burns ameliorates muscle catabolism","volume":"29","author":"Ferrando","year":"2001","journal-title":"Crit Care Med"},{"key":"R39-20230913","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1172\/JCI110903","article-title":"Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes","volume":"71","author":"Loose","year":"1983","journal-title":"J Clin Invest"},{"key":"R40-20230913","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-97-3-370","article-title":"Ketoconazole blocks adrenal steroid synthesis","volume":"97","author":"Pont","year":"1982","journal-title":"Ann Intern Med"},{"key":"R41-20230913","doi-asserted-by":"crossref","first-page":"e35465","DOI":"10.1371\/journal.pone.0035465","article-title":"The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes","volume":"7","author":"Jeschke","year":"2012","journal-title":"PLosS One"},{"key":"R42-20230913","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00000658-200104000-00012","article-title":"Anabolic effects of oxandrolone after severe burn","volume":"233","author":"Hart","year":"2001","journal-title":"Ann Surg"},{"key":"R43-20230913","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/jcrc.2000.0150012","article-title":"The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury","volume":"15","author":"Demling","year":"2000","journal-title":"J Crit Care"},{"key":"R44-20230913","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.BCR.0000202620.55751.4F","article-title":"Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial","volume":"27","author":"Wolf","year":"2006","journal-title":"J Burn Care Res"},{"key":"R45-20230913","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/SLA.0b013e318146980e","article-title":"The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn","volume":"246","author":"Jeschke","year":"2007","journal-title":"Ann Surg"},{"key":"R46-20230913","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0305-4179(00)00064-4","article-title":"The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent","volume":"27","author":"Demling","year":"2001","journal-title":"Burns"},{"key":"R47-20230913","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.surg.2004.04.022","article-title":"Effects of long-term oxandrolone administration in severely burned children","volume":"136","author":"Murphy","year":"2004","journal-title":"Surgery"},{"key":"R48-20230913","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jamcollsurg.2011.12.038","article-title":"Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy","volume":"214","author":"Porro","year":"2012","journal-title":"J Am Coll Surg"},{"key":"R49-20230913","doi-asserted-by":"crossref","DOI":"10.1097\/BCR.0000000000000356","article-title":"Long-term administration of oxandrolone improves lung function in pediatric burned patients","author":"Sousse","year":"2016","journal-title":"J Burn Care Res"},{"key":"R50-20230913","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/SHK.0000000000000517","article-title":"Five-year outcomes after long-term oxandrolone administration in severely burned children: a randomized clinical trial","volume":"45","author":"Reeves","year":"2016","journal-title":"Shock"},{"key":"R51-20230913","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa010342","article-title":"Reversal of catabolism by beta-blockade after severe burns","volume":"345","author":"Herndon","year":"2001","journal-title":"N Engl J Med"},{"key":"R52-20230913","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.surg.2010.05.015","article-title":"Propranolol decreases cardiac work in a dose-dependent manner in severely burned children","volume":"149","author":"Williams","year":"2010","journal-title":"Surgery"},{"key":"R53-20230913","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00000658-200210000-00007","article-title":"Beta-blockade and growth hormone after burn","volume":"236","author":"Hart","year":"2002","journal-title":"Ann Surg"},{"key":"R54-20230913","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/PCC.0b013e318166d414","article-title":"Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children","volume":"9","author":"Jeschke","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R55-20230913","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/00005373-200110000-00019","article-title":"Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications","volume":"51","author":"Barret","year":"2001","journal-title":"J Trauma"},{"key":"R56-20230913","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/9780470059593.ch16","article-title":"Beta-blockade in burns","volume":"280","author":"Pereira","year":"2007","journal-title":"Novartis Found Symp"},{"key":"R57-20230913","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SLA.0b013e318265427e","article-title":"Long-term propranolol use in severely burned pediatric patients: a randomized controlled study","volume":"256","author":"Herndon","year":"2012","journal-title":"Ann Surg"},{"key":"R58-20230913","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.TA.0000026990.32856.58","article-title":"Metformin blunts stress-induced hyperglycemia after thermal injury","volume":"54","author":"Gore","year":"2003","journal-title":"J Trauma"},{"key":"R59-20230913","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/01.sla.0000152013.23032.d1","article-title":"Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury","volume":"241","author":"Gore","year":"2005","journal-title":"Ann Surg"},{"key":"R60-20230913","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001845","article-title":"Glucose control in severely burned patients using metformin- an interim safety and efficacy analysis of a Phase II randomized controlled trial","author":"Jeschke","year":"2016","journal-title":"Ann Surg"},{"key":"R61-20230913","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"R62-20230913","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.sla.0000250409.51289.ca","article-title":"Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate","volume":"245","author":"Cree","year":"2007","journal-title":"Ann Surg"},{"key":"R63-20230913","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/cc7874","article-title":"The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study","volume":"13","author":"Deane","year":"2009","journal-title":"Crit Care"},{"key":"R64-20230913","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1152\/ajpendo.2001.280.2.E270","article-title":"A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle","volume":"280","author":"Minnich","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075198-201608000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:15:18Z","timestamp":1694632518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075198-201608000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000330","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}